Blackrock-UBS deal a sign buyers returning to subprime

By Laurence Fletcher and Douwe Miedema

LONDON/ZURICH (Reuters) - BlackRock's (BLK.N: Quote, Profile, Research, Stock Buzz) purchase of a massive subprime portfolio from UBS (UBSN.VX: Quote, Profile, Research, Stock Buzz) is a sign that first buyers are returning to assets long considered too toxic to touch, and more similar deals may follow.

Under the deal, expected to be finalized this month, the U.S. asset manager will take a portfolio with a notional value of $22 billion off the Swiss bank's books for $15 billion, making it the biggest of its kind so far.

"It's quite a significant deal, because what we're beginning to see is that private capital is coming in and is willing to buy," said David Williams, analyst at Fox-Pitt Kelton.

"It suggests the market is freeing up a bit. It suggests the smart money can commit money to this, when six months ago it would not look at it," he said.

However, the opacity of the deal, announced last week, makes it hard to be sure exactly how brave a purchase it is.

Few details of the portfolio have been revealed, other than that it consists of subprime and Alt-A -- which range from near-prime to near-subprime -- bonds, rather than structured products, priced at an average 68 cents to the dollar.

"I'd imagine it is probably not very low in the capital structure. It is not a huge discount to face value given some of the very toxic writedowns that have already taken place," said John Jay, senior analyst at Aite Group. "The number and then the discount didn't strike me as BBB."

UBS has said it would sell the portfolio, which has a value of $15 billion on its books, without a "loss or a gain", implying a 32 percent discount to the notional value.